MS Pen Technologies specializes in the application of the MasSpec Pen, a novel probe which enables real-time biochemical analysis.
The MasSpec Pen is a handheld pen-like device that rapidly identifies the molecular profile of tissues using a small volume water droplet and mass spectrometry analysis. After 3 seconds of gentle physical contact with a tissue surface, the water droplet is transported to a mass spectrometer, which characterizes diagnostic proteins, lipids, and metabolites. Using machine learning algorithm, a diagnosis is provided with an associate probability of presence of cancer. The pen could be used to rapidly distinguish tumor from healthy tissue during surgery in mice, without requiring specific labeling or imaging and without evidence of tissue destruction.President and CEO: Shannon D. Green
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 23, 2020 | Seed | $1.25M | 1 | i2E Management Company | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
i2E Management Company | Yes | Seed |